NEW YORK ─ The US Food and Drug Administration on Friday reissued an Emergency Use Authorization for the Thermo Fisher Scientific TaqPath COVID-19 Combo Kit and expanded it to include an additional sample collection kit provided by Austin, Texas-based Everlywell as well as a new workflow.
In March, Thermo Fisher's test was the second commercial diagnostic assay to be granted EUA.